凯塔米尔-2,一个新的分子实体和新的胺类相应物
Itzchak Angel1, Rita Perelroizen2, Wendy Deffains3
1Mira Pharmaceuticals Inc., Miami, FL, United States.
凯塔米尔-2是一种新的胺类同类物质,通过选择性向NMDA受体而不会引起超位运动,显示出作为更安全的抗抑郁药和焦虑解消剂的潜力. 与传统的胺治疗相比,这种新实体提供了改善的口服生物可用性和更高的安全性.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
背景情况:
- 胺是用于抑郁症和疼痛的NMDA受体对手,但它有局限性,包括口服生物可用性差以及潜在的心理仿真副作用.
- 新的胺类类似物正在开发中,以提高疗效和安全性.
- 了解新类型的特定受体相互作用和行为影响对于治疗开发至关重要.
研究的目的:
- 描述Ketamir-2,一种新的胺类类似物,重点关注其受体结合特征,口服生物可用性,安全性以及潜在的抗抑郁和抗焦虑作用.
- 在临床前模型中,将Ketamir-2的药理和行为效应与胺相比较.
- 评估Ketamir-2的选择性和安全性,特别是缺乏催促超位运动的情况.
主要方法:
- 进行了受体结合测定,以确定Ketamir-2对NMDA受体PCP位点和其他受体的亲和力和选择性.
- 用小鼠进行药理学试验,包括开放场测试,高空迷宫和强迫游泳测试,用于评估抗抑郁药和抗焦虑药的效果.
- 在口服Ketamir-2和胺剂后,在小鼠中测量了超口腔动作,以比较行为副作用.
主要成果:
- 凯他米-2对NMDA受体PCP位点的亲和力很低 (IC50 ≈ 100 μM),比凯他胺具有更大的选择性.
- 与胺类药物不同的是,Ketamir-2在口服后不会在小鼠中诱导超位运动.
- 在行为测定中,Ketamir-2表现出显著的抗抑郁和抗焦虑作用,通常表现优于 ketamine,与载体相比显示出混合或相反的结果.
结论:
- 凯塔米尔-2 是一种新的胺类同类药物,由于其选择性NMDA受体对抗性和缺乏超位运动,因此具有潜在的安全性.
- 它在临床前模型中的有效性表明它可能成为抑郁症和焦虑症治疗的治疗剂.
- 对Ketamir-2的药理动力学和药理动力学特性进行进一步的研究是有必要的,以探索其临床实用性.
更多相关视频
09:08From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028
Published on: January 13, 2017
10:16Autoradiography as a Simple and Powerful Method for Visualization and Characterization of Pharmacological Targets
Published on: March 12, 2019
相关概念视频
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Parenteral Anesthetics: Overview
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Phase II Reactions: Methylation Reactions
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
